About Maneesh Pharmaceuticals Limited
Data last updated:
Maneesh Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1985PLC036952. Its GSTIN is 27AAACM3635Q1Z2 (Maharashtra). The company holds 16 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹28.13 Cr. It was formerly known as Maneesh Pharmaceuticals Private Limited and Maneesh Pharmaceuticals Pvt. Ltd. It is led by directors including Maneesh Ramakant Sapte (Whole-Time Director) and Ajit Gopal Jamkhandikar.
Its last annual general meeting (AGM) was held on 11 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 29/33 Ancillary Industrial Plots Govandi, Mumbai, Maharashtra, India – 400043.
As per the financials filed for FY 2022, the company reported a revenue of ₹534.48 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹56.02 Cr (net margin 10.5%) and EBITDA of ₹72.68 Cr (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 18% over five years.
The company has about 1,204 employees on its provident fund (EPFO) records. Its group structure includes 5 subsidiaries.
The company is associated with 1 brand: Maneesh Pharmaceuticals. As per MCA filings, the company has open charges of ₹18 Cr and satisfied charges of ₹1,045.43 Cr on record. Court records list 155 cases involving the company, including 79 filed by the company and 76 filed against it; 28 cases are pending. The company has 46 deals on record (37 secondary share transfers, 8 funding rounds, 1 rights issue), with disclosed funding of ₹158.95 Cr; the latest was in March 2022. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is German Remedies Pharmaceuticals Private Limited with revenue of ₹546.98 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 688 overdue payments to 54 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maneeshpharma.com.
Company details
Name history
Maneesh Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Maneesh Pharmaceuticals Private Limited, and Maneesh Pharmaceuticals Pvt. Ltd.. The current legal name is Maneesh Pharmaceuticals Limited.
| Company Name | Status |
|---|---|
| Maneesh Pharmaceuticals Limited | Current |
| Maneesh Pharmaceuticals Private Limited | Previous |
| Maneesh Pharmaceuticals Pvt. Ltd. | Previous |
CIN history
Maneesh Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH1985PTC036952. The current CIN is U24230MH1985PLC036952, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1985PLC036952 | Current |
| U24230MH1985PTC036952 | Previous |
Contact details
Maneesh Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is maneeshpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address29/33 Ancillary Industrial Plots Govandi, Mumbai, Maharashtra, India – 400043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maneesh Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maneesh Pharmaceuticals operates one associated brand: Maneesh Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Branded formulations and generics are manufactured for therapeutic categories. | maneeshpharma.com |
Business activity
The main business activity of Maneesh Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maneesh Pharmaceuticals Limited, buy the company report.
Financials of Maneesh Pharmaceuticals Limited
FY 2023 filings availableManeesh Pharmaceuticals Limited reported revenue of ₹534.48 Cr (up 28% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 28% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56.02 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | ||||
| Net Profit Margin | 10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maneesh Pharmaceuticals Limited, buy the company report.
Board of directors and KMP of Maneesh Pharmaceuticals Limited
Maneesh Pharmaceuticals Limited currently reports 5 directors and 1 key managerial person. 13 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maneesh Ramakant Sapte | Whole-Time Director | 01 Oct 2002 | 24 Years 1 Months | Current |
| Ajit Gopal Jamkhandikar Also directs: Phaarmasia Limited | Director | 24 Aug 2018 | 8 Years 2 Months | Current |
| Pravin Mohandas Hegde Also directs: Phaarmasia Limited, Master Mind Property Private Limited | Director | 19 Jan 2017 | 9 Years 9 Months | Current |
| Rakesh Khetan Tunaram Also directs: Bzi Growth Private Limited | Cfo | 20 Mar 2015 | 11 Years 7 Months | Current |
| Rashmi Vinay Sapte Also directs: Phaarmasia Limited, Zypcare Lifesciences Private Limited, Svizera Labs Private Limited and 3 more | Director | 30 Mar 2007 | 19 Years 7 Months | Current |
| Vinay Ramakant Sapte | Director | 25 Jul 1985 | 41 Years 3 Months | Current |
Peer comparison
Maneesh Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| German Remedies Pharmaceuticals Private Limited | ₹546.98 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Kusum Healthcare Private Limited | ₹537.89 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Unison Pharmaceuticals Private Limited | ₹537.1 Cr (FY 2025) | 23.0% | Ahmedabad, Gujarat, India | |||
| Maneesh Pharmaceuticals Limitedthis company | ₹534.48 Cr (FY 2022) | ₹56.02 Cr | 10.5% | 28.0% | 1,204 | Mumbai, Maharashtra, India |
| Mapaex Health and Personalcare Private Limited | ₹514.15 Cr (FY 2024) | 23.0% | Bhopal, Madhya Pradesh, India | |||
| Cronus Pharma Specialities India Private Limited | ₹484.74 Cr (FY 2025) | 64.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Maneesh Pharmaceuticals Limited, buy the company report.
Auditor
Maneesh Pharmaceuticals Limited is audited by M. M. NISSIM & Co. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. M. NISSIM & Co. | FY 2021 | 107122W |
Shareholding
The shareholding of Maneesh Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maneesh Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jul 2004 | 80047136 | Export-Import Bank of India | ₹18 Cr | Open | |
| 28 Dec 2011 | 10330367 | Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited | ₹110.58 Cr | Satisfied | |
| 18 Feb 2011 | 10273942 | Icici Bank Limited | ₹18.5 Cr | Satisfied | |
| 05 Mar 2010 | 10206827 | Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited | ₹10 Cr | Satisfied | |
| 11 Oct 2008 | 10127537 | 3I Infotech Trusteeship Services Limited | ₹25 Cr | Satisfied |
To see the full charge records of Maneesh Pharmaceuticals Limited, buy the company report.
Total charge records: 36 View all charges
Deals & funding
Maneesh Pharmaceuticals Limited has 46 deals on record (37 secondary share transfers, 8 funding rounds, 1 rights issue), with disclosed funding of ₹158.95 Cr; the latest was in March 2022.
Deals on record (5 of 46)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Chanakya Corporate Services Private Limited Seller: Calculas Financial Consultants Privnate Limited |
| Jan 2021 | Secondary share transfer | Undisclosed | Buyer: Calculas Financial Consultants Privnate Limited Seller: Chanakya Corporate Services Private Limited |
| Mar 2015 | Rights issue | ₹18.75 Cr | Investors: 4 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Sarvamangal Mercantile Co.Limited, 3 individuals Seller: Oricon Properties Private Limited , 3 individuals |
| May 2013 | Funding round | ₹12.5 Cr | Investors: 4 individuals |
To see the full deal history of Maneesh Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maneesh Pharmaceuticals Limited has 155 court cases on record: 79 filed by Maneesh Pharmaceuticals, 76 filed against it. 28 cases are pending and 127 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 100 | 42 | 17 |
| District courts | 35 | 20 | 9 |
| Supreme Court | 14 | 9 | 1 |
| NCLAT | 4 | 4 | 0 |
| NCLT | 2 | 1 | 1 |
Cases on record (5 of 155)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Himachal Pradesh | Writ petition | Filed by the company against M/S Nichepharm Lifesciences Pvt. Ltd. and 1 other | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed against the company by Vistra Itcl (India) Limited | Disposed |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Union Bank of India and 3 others | Disposed |
| Bombay High Court | Court case (APP) | Filed by the company against M/S Contract Advertising India Private Limited | Disposed |
| Bombay High Court | Court case (APEAL) | Filed by the company against M/S. Ray Pharmaceuticals Ltd and Ors | Disposed |
To see the full case history of Maneesh Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Maneesh Pharmaceuticals Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 688 overdue payments to 54 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 54)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pontika Aerotech Limited | |||
| an individual supplier | |||
| Raj Enterprises | |||
| Pure Impressions Printech Private Limited | |||
| S.S.Enterprises |
To see the full MSME payment records of Maneesh Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Maneesh Pharmaceuticals has 5 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Phaarmasia Limited | L24239TG1981PLC002915 | |
| Pharmanova Specialties Private Limited | U24233MH2014PTC252718 | |
| Ergos Life Sciences Private Limited | U24303MH2017PTC292787 | |
| Svizera Labs Private Limited | U74999MH1997PTC107389 | |
| Shanbag Storage and Services Private Limited | U74999MH2010PTC201092 |
To see the full group structure of Maneesh Pharmaceuticals Limited, buy the company report.
Employees & EPFO
Maneesh Pharmaceuticals Limited has a workforce of 1,204 employees on its EPFO records as of Feb 27, 2025, across 4 active EPFO establishments.
GST
Maneesh Pharmaceuticals has 16 GST registrations: 2 active and 14 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM3635Q1Z2 | Maharashtra | Active | 01 Jul 2017 |
| 02AAACM3635Q1ZE | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maneesh Pharmaceuticals Limited, buy the company report.
Recent activity
Maneesh Pharmaceuticals Limited has 14 board changes on record since 1985: 6 appointments and 8 cessations. The latest: Maneesh Ramakant Sapte ceased to be Director on 31 Mar 2023.
88 earlier events are in the company report.
Frequently asked questions
Maneesh Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 1985 (41+ years old) and is registered under CIN U24230MH1985PLC036952.
Maneesh Pharmaceuticals has 6 current directors and KMP:
- Maneesh Ramakant Sapte - Whole-Time Director
- Ajit Gopal Jamkhandikar - Director
- Pravin Mohandas Hegde - Director
- Rashmi Vinay Sapte - Director
- Vinay Ramakant Sapte - Director
- Rakesh Khetan Tunaram - Cfo
The latest financial statements of Maneesh Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 11 July 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Maneesh Pharmaceuticals is 27AAACM3635Q1Z2, registered in Maharashtra. The company has 16 GST registrations in all, of which 2 are active and 14 are cancelled or inactive. Other active GSTINs include 02AAACM3635Q1ZE (Himachal Pradesh).
The CIN (Corporate Identification Number) of Maneesh Pharmaceuticals is U24230MH1985PLC036952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maneesh Pharmaceuticals has 155 court cases on record: 79 filed by the company and 76 filed against it. 28 are pending. Most are in the high courts.
Maneesh Pharmaceuticals was incorporated on 25 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
Maneesh Pharmaceuticals has 46 deals on record (37 secondary share transfers, 8 funding rounds, 1 rights issue), with disclosed funding of ₹158.95 Cr; the latest was in March 2022.
The peers of Maneesh Pharmaceuticals by revenue are German Remedies Pharmaceuticals Private Limited, Graviti Pharmaceuticals Private Limited, Kusum Healthcare Private Limited, Unison Pharmaceuticals Private Limited, Mapaex Health and Personalcare Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Maneesh Ramakant Sapte ceased to be Director on 31 Mar 2023. Vinay Ramakant Sapte ceased to be Managing Director on 31 Mar 2023. Ajit Gopal Jamkhandikar ceased to be Additional Director on 18 Sep 2018. Maneesh Pharmaceuticals has 14 board changes on record in total.
Maneesh Pharmaceuticals has 10 MSME Form 1 returns on record between 2019 and 2024, listing 688 overdue payments to 54 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Maneesh Pharmaceuticals can be reached through the website maneeshpharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
